762918.fig.003
Figure 3: The effect of KIOM-MA and KIOM-MA128 on atopic dermatitis-induced BALB/c mice. KIOM-MA and KIOM-MA128 significantly mitigated five symptoms: erythema/darkening, edema/population, excoriations, lichenification/prurigo, and dryness at 7 days after treatment.